Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q4 2024 (December 31)2holders +1
1new positions
0sold out
$1.09avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.2M) and Jane Street Group, LLC ($1.3M).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.3M |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 1,225,000 shares bought, net +1,225,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,000,000 | $2.2M |
| Jane Street Group, LLC | 0.00% | New | 1,225,000 | $1.3M |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.